prognostic indicators

Blood Test Predicts Treatment Response for NETs

06/27/2016

JCP Editors

A study presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (June 11-15; San Diego, CA [SNMMI]) has found that a novel investigative blood test could predict how patients with...

A...

06/27/2016

Journal of Clinical Pathways

Research in Review

Blood Biomarkers Useful for Understanding NSCLC Prognosis

06/20/2016

JCP Editors

A study of patients with inoperable non-small cell lung cancer (NSCLC) has found that certain blood biomarkers may have prognostic value and could enhance treatment decision-making for providers.  To...

...

06/20/2016

Journal of Clinical Pathways

Scoring System Predicts GI Cancer Survival

06/17/2016

JCP Editors

A team of investigators has developed a scoring system that may inform decision-making for the treatment of gastrointestinal neuroendocrine carcinomas. With the scoring system, patients are assigned a score from 0...

A team...

06/17/2016

Journal of Clinical Pathways

Biomarker-Guided Therapy Leads to Improved Response in Phase 1 Trials

06/05/2016

JCP Editors

Using biomarkers to guide treatment in clinical trials may yield higher response rates than similar drugs not guided by biomarkers, according to an abstract presented at the American Society of Clinical Oncology...

...

06/05/2016

Journal of Clinical Pathways

Tumor Location an Influencer of Survival in Patients With Colorectal Cancer

06/04/2016

JCP Editors

The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer (mCRC), according to results from a large retrospective study presented at the American Society...

The...

06/04/2016

Journal of Clinical Pathways

Research in Review

Integrative Genomic Approach to Cancer Care Leads to More Actionable Variants

06/02/2016

JCP Editors

A genomic approach developed and tested by scientists at the Icahn School of Medicine at Mount Sinai (New York City, NY) helped support decision-making and led to therapeutic recommendations for a group of patients...

A...

06/02/2016

Journal of Clinical Pathways

Research in Review

Breast Cancer Biomarker of Chemotherapy Resistance Identified

05/26/2016

JCP Editors

Expression of methylation-controlled J protein (MCJ) may be an indicator of successful outcomes and reduced risk of relapse in patients with breast cancer, according to a recent study. Chemotherapy is a key part of...

...

05/26/2016

Journal of Clinical Pathways

Research in Review

Nutritional Status an Indicator of Survival in Patients With Esophageal Cancer

05/25/2016

JCP Editors

Nutritional status may be a prominent indicator of survival in elderly patients with esophageal cancer, claims a recently published study. Esophageal cancer is one of the leading causes of cancer-related death...

...

05/25/2016

Journal of Clinical Pathways

Research in Review

Weight Gain a Sign of Successful Treatment in Patients With NSCLC

05/24/2016

JCP Editors

Weight gain may be an indicator of successful treatment for patients with non-small cell lung cancer (NSCLC), according to findings from a recently published article. Past studies have linked unintentional weigh...

Weight...

05/24/2016

Journal of Clinical Pathways

Research in Review

Novel Biomarker Predicts Treatment Response in NSCLC

05/19/2016

JCP Editors

A study of SMARCA/BRG1 expression in patients with non-small cell lung (NSCLC) cancer has found that it is a significant indicator of prognosis and a novel predictive biomarker for increased sensitivity to...

A...

05/19/2016

Journal of Clinical Pathways